Clinical Trial

Clinical Study of 18F-Exendin-4 in Insulinoma

Name: Clinical Study of 18F-Exendin-4 in Insulinoma — clinical trial record (NCT07340437)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The goal of this observational study is to evaluate the diagnostic value of ¹⁸F-Exendin-4 PET/CT imaging in renal insulinoma. Participants will undergo clinical evaluation and ¹⁸F-Exendin-4 PET/CT examination.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-06.

Trial Details

NCT Number	NCT07340437
Lead Sponsor	Sichuan Provincial People's Hospital
Conditions	Insulinoma
Enrollment	20 participants
Start Date	2023-02-01
Primary Completion	2025-10-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-15